catechin has been researched along with Malignant Melanoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nguyen, M | 1 |
| Marcellus, RC | 1 |
| Roulston, A | 1 |
| Watson, M | 1 |
| Serfass, L | 1 |
| Murthy Madiraju, SR | 1 |
| Goulet, D | 1 |
| Viallet, J | 1 |
| Bélec, L | 1 |
| Billot, X | 1 |
| Acoca, S | 1 |
| Purisima, E | 1 |
| Wiegmans, A | 1 |
| Cluse, L | 1 |
| Johnstone, RW | 1 |
| Beauparlant, P | 1 |
| Shore, GC | 1 |
1 other study available for catechin and Malignant Melanoma
| Article | Year |
|---|---|
Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis.
Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; Boronic Acids | 2007 |